Stay updated on Zanidatamab Combo in HER2+ Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Zanidatamab Combo in HER2+ Gastric Cancer Clinical Trial page.

Latest updates to the Zanidatamab Combo in HER2+ Gastric Cancer Clinical Trial page
- Check2 days agoChange DetectedThe site footer now identifies the ClinicalTrials.gov website as revision v3.7.1 instead of v3.7.0.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedA new history entry dated 2026-09-22 introduces the Study Status section and is followed by a 2026-09-24 update; the 2026-09-01 entry was removed from the version history.SummaryDifference0.2%

- Check23 days agoChange DetectedA new revision entry v3.7.0 was added to the record history, signaling an update to the study record. The previous revision v3.6.6 is shown as the earlier version in the diff.SummaryDifference0.1%

- Check37 days agoChange DetectedIPDSharing and Study Status entries were added to the record history, and the 2026-07-17 entry was removed. These updates reflect changes to data-sharing metadata and the tracking of the study's status within the history page.SummaryDifference0.3%

- Check44 days agoChange DetectedThe page footer revision label was updated from v3.6.5 to v3.6.6, representing a software version update for the study history page. This change does not affect study data, eligibility, locations, or other user-facing content.SummaryDifference0.1%

- Check58 days agoChange DetectedA new page revision entry (v3.6.5) was added to the history and the previous revision (v3.6.4) was removed, indicating an update to the page's version or template used for the Record History page.SummaryDifference0.0%

Stay in the know with updates to Zanidatamab Combo in HER2+ Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Zanidatamab Combo in HER2+ Gastric Cancer Clinical Trial page.